nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronedarone—ALB—multiple sclerosis	0.225	1	CbGaD
Dronedarone—CYP2D6—Fingolimod—multiple sclerosis	0.0418	0.126	CbGbCtD
Dronedarone—ALB—Prednisone—multiple sclerosis	0.0331	0.0994	CbGbCtD
Dronedarone—ABCB1—Methylprednisolone—multiple sclerosis	0.0286	0.0858	CbGbCtD
Dronedarone—CYP3A4—Fingolimod—multiple sclerosis	0.0266	0.0798	CbGbCtD
Dronedarone—ABCB1—Mitoxantrone—multiple sclerosis	0.0209	0.0626	CbGbCtD
Dronedarone—ABCB1—Betamethasone—multiple sclerosis	0.0186	0.0558	CbGbCtD
Dronedarone—ABCB1—Prednisolone—multiple sclerosis	0.0184	0.0551	CbGbCtD
Dronedarone—ABCB1—Prednisone—multiple sclerosis	0.0173	0.052	CbGbCtD
Dronedarone—CYP3A4—Methylprednisolone—multiple sclerosis	0.0171	0.0514	CbGbCtD
Dronedarone—ALB—Methotrexate—multiple sclerosis	0.0166	0.0499	CbGbCtD
Dronedarone—CYP3A4—Triamcinolone—multiple sclerosis	0.013	0.039	CbGbCtD
Dronedarone—CYP3A4—Mitoxantrone—multiple sclerosis	0.0125	0.0375	CbGbCtD
Dronedarone—CYP3A4—Betamethasone—multiple sclerosis	0.0111	0.0334	CbGbCtD
Dronedarone—CYP3A4—Prednisolone—multiple sclerosis	0.011	0.033	CbGbCtD
Dronedarone—ABCB1—Dexamethasone—multiple sclerosis	0.0108	0.0325	CbGbCtD
Dronedarone—CYP3A4—Prednisone—multiple sclerosis	0.0104	0.0312	CbGbCtD
Dronedarone—CYP2D6—Dexamethasone—multiple sclerosis	0.0102	0.0306	CbGbCtD
Dronedarone—Traumatic liver injury—Fingolimod—multiple sclerosis	0.00967	0.0635	CcSEcCtD
Dronedarone—ABCB1—Methotrexate—multiple sclerosis	0.0087	0.0261	CbGbCtD
Dronedarone—CYP3A4—Dexamethasone—multiple sclerosis	0.00648	0.0195	CbGbCtD
Dronedarone—CACNA1F—retina—multiple sclerosis	0.00465	0.0352	CbGeAlD
Dronedarone—Pulmonary fibrosis—Cladribine—multiple sclerosis	0.00464	0.0305	CcSEcCtD
Dronedarone—HCN1—nervous system—multiple sclerosis	0.00439	0.0333	CbGeAlD
Dronedarone—Liver injury—Fingolimod—multiple sclerosis	0.00428	0.0281	CcSEcCtD
Dronedarone—HCN1—central nervous system—multiple sclerosis	0.00423	0.032	CbGeAlD
Dronedarone—HCN3—medulla oblongata—multiple sclerosis	0.00358	0.0271	CbGeAlD
Dronedarone—HCN2—medulla oblongata—multiple sclerosis	0.00336	0.0254	CbGeAlD
Dronedarone—HCN1—brain—multiple sclerosis	0.00336	0.0254	CbGeAlD
Dronedarone—HCN4—nervous system—multiple sclerosis	0.00333	0.0252	CbGeAlD
Dronedarone—HCN3—midbrain—multiple sclerosis	0.00328	0.0248	CbGeAlD
Dronedarone—HCN4—central nervous system—multiple sclerosis	0.00321	0.0243	CbGeAlD
Dronedarone—HCN2—midbrain—multiple sclerosis	0.00307	0.0232	CbGeAlD
Dronedarone—HCN2—spinal cord—multiple sclerosis	0.00299	0.0227	CbGeAlD
Dronedarone—Pulmonary toxicity—Methotrexate—multiple sclerosis	0.00295	0.0193	CcSEcCtD
Dronedarone—Eczema—Fingolimod—multiple sclerosis	0.00291	0.0191	CcSEcCtD
Dronedarone—Interstitial lung disease—Cladribine—multiple sclerosis	0.00289	0.0189	CcSEcCtD
Dronedarone—HCN3—nervous system—multiple sclerosis	0.00269	0.0204	CbGeAlD
Dronedarone—Rash erythematous—Cladribine—multiple sclerosis	0.00267	0.0175	CcSEcCtD
Dronedarone—HCN3—central nervous system—multiple sclerosis	0.00259	0.0196	CbGeAlD
Dronedarone—HCN4—brain—multiple sclerosis	0.00254	0.0193	CbGeAlD
Dronedarone—HCN3—cerebellum—multiple sclerosis	0.00253	0.0192	CbGeAlD
Dronedarone—HCN2—nervous system—multiple sclerosis	0.00252	0.0191	CbGeAlD
Dronedarone—HCN2—central nervous system—multiple sclerosis	0.00243	0.0184	CbGeAlD
Dronedarone—HCN2—cerebellum—multiple sclerosis	0.00237	0.018	CbGeAlD
Dronedarone—Interstitial lung disease—Azathioprine—multiple sclerosis	0.00235	0.0154	CcSEcCtD
Dronedarone—CACNB4—medulla oblongata—multiple sclerosis	0.00221	0.0167	CbGeAlD
Dronedarone—HCN3—brain—multiple sclerosis	0.00206	0.0156	CbGeAlD
Dronedarone—Pneumonia—Fingolimod—multiple sclerosis	0.00203	0.0133	CcSEcCtD
Dronedarone—CACNB4—midbrain—multiple sclerosis	0.00202	0.0153	CbGeAlD
Dronedarone—Liver injury—Azathioprine—multiple sclerosis	0.00197	0.013	CcSEcCtD
Dronedarone—CACNB4—spinal cord—multiple sclerosis	0.00197	0.0149	CbGeAlD
Dronedarone—HCN2—brain—multiple sclerosis	0.00193	0.0146	CbGeAlD
Dronedarone—Interstitial lung disease—Mitoxantrone—multiple sclerosis	0.0019	0.0125	CcSEcCtD
Dronedarone—ADRA2A—peripheral nervous system—multiple sclerosis	0.00184	0.014	CbGeAlD
Dronedarone—Bradycardia—Fingolimod—multiple sclerosis	0.00184	0.0121	CcSEcCtD
Dronedarone—CACNB1—medulla oblongata—multiple sclerosis	0.00176	0.0134	CbGeAlD
Dronedarone—Vasculitis—Azathioprine—multiple sclerosis	0.0017	0.0112	CcSEcCtD
Dronedarone—CACNB3—medulla oblongata—multiple sclerosis	0.00169	0.0128	CbGeAlD
Dronedarone—Cardiac disorder—Fingolimod—multiple sclerosis	0.00168	0.011	CcSEcCtD
Dronedarone—CACNB4—nervous system—multiple sclerosis	0.00166	0.0126	CbGeAlD
Dronedarone—Angiopathy—Fingolimod—multiple sclerosis	0.00164	0.0108	CcSEcCtD
Dronedarone—Mediastinal disorder—Fingolimod—multiple sclerosis	0.00163	0.0107	CcSEcCtD
Dronedarone—CACNB1—midbrain—multiple sclerosis	0.00161	0.0122	CbGeAlD
Dronedarone—CACNB4—central nervous system—multiple sclerosis	0.0016	0.0121	CbGeAlD
Dronedarone—SCN1A—brainstem—multiple sclerosis	0.00158	0.012	CbGeAlD
Dronedarone—CACNB1—spinal cord—multiple sclerosis	0.00157	0.0119	CbGeAlD
Dronedarone—CACNB2—retina—multiple sclerosis	0.00157	0.0119	CbGeAlD
Dronedarone—CACNB4—cerebellum—multiple sclerosis	0.00156	0.0118	CbGeAlD
Dronedarone—CACNB3—midbrain—multiple sclerosis	0.00155	0.0117	CbGeAlD
Dronedarone—Pulmonary fibrosis—Methotrexate—multiple sclerosis	0.00152	0.00998	CcSEcCtD
Dronedarone—Cardiac failure—Cladribine—multiple sclerosis	0.00152	0.00997	CcSEcCtD
Dronedarone—Dermatitis atopic—Prednisolone—multiple sclerosis	0.00149	0.00977	CcSEcCtD
Dronedarone—Dermatitis atopic—Triamcinolone—multiple sclerosis	0.00137	0.00898	CcSEcCtD
Dronedarone—Leukocytoclastic vasculitis—Methotrexate—multiple sclerosis	0.00136	0.00895	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.00133	0.00874	CcSEcCtD
Dronedarone—CACNB1—nervous system—multiple sclerosis	0.00133	0.01	CbGeAlD
Dronedarone—CACNB1—central nervous system—multiple sclerosis	0.00128	0.00966	CbGeAlD
Dronedarone—CACNB3—nervous system—multiple sclerosis	0.00127	0.00962	CbGeAlD
Dronedarone—CACNB4—brain—multiple sclerosis	0.00127	0.0096	CbGeAlD
Dronedarone—Nervous system disorder—Fingolimod—multiple sclerosis	0.00126	0.00828	CcSEcCtD
Dronedarone—Skin disorder—Fingolimod—multiple sclerosis	0.00125	0.0082	CcSEcCtD
Dronedarone—CACNB1—cerebellum—multiple sclerosis	0.00125	0.00944	CbGeAlD
Dronedarone—CACNB3—central nervous system—multiple sclerosis	0.00122	0.00926	CbGeAlD
Dronedarone—Rash erythematous—Dexamethasone—multiple sclerosis	0.0012	0.00788	CcSEcCtD
Dronedarone—Rash erythematous—Betamethasone—multiple sclerosis	0.0012	0.00788	CcSEcCtD
Dronedarone—CACNB3—cerebellum—multiple sclerosis	0.0012	0.00906	CbGeAlD
Dronedarone—Pneumonia—Cladribine—multiple sclerosis	0.00115	0.00754	CcSEcCtD
Dronedarone—Vasculitis—Prednisolone—multiple sclerosis	0.00113	0.00741	CcSEcCtD
Dronedarone—KCNK2—brain—multiple sclerosis	0.00112	0.00851	CbGeAlD
Dronedarone—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00111	0.00729	CcSEcCtD
Dronedarone—Fatigue—Fingolimod—multiple sclerosis	0.00111	0.00728	CcSEcCtD
Dronedarone—SCN1A—medulla oblongata—multiple sclerosis	0.00111	0.00836	CbGeAlD
Dronedarone—Dermatitis atopic—Prednisone—multiple sclerosis	0.00108	0.0071	CcSEcCtD
Dronedarone—Hepatobiliary disease—Cladribine—multiple sclerosis	0.00108	0.00709	CcSEcCtD
Dronedarone—Cardiac failure congestive—Mitoxantrone—multiple sclerosis	0.00107	0.00706	CcSEcCtD
Dronedarone—Vasculitis—Triamcinolone—multiple sclerosis	0.00104	0.00681	CcSEcCtD
Dronedarone—Vasculitis—Methylprednisolone—multiple sclerosis	0.00104	0.0068	CcSEcCtD
Dronedarone—CACNB1—brain—multiple sclerosis	0.00101	0.00767	CbGeAlD
Dronedarone—SCN1A—midbrain—multiple sclerosis	0.00101	0.00765	CbGeAlD
Dronedarone—Cardiac failure—Mitoxantrone—multiple sclerosis	0.000999	0.00656	CcSEcCtD
Dronedarone—SCN1A—spinal cord—multiple sclerosis	0.000985	0.00746	CbGeAlD
Dronedarone—CACNB3—brain—multiple sclerosis	0.000972	0.00736	CbGeAlD
Dronedarone—Cardiac disorder—Cladribine—multiple sclerosis	0.000952	0.00625	CcSEcCtD
Dronedarone—Interstitial lung disease—Methotrexate—multiple sclerosis	0.000945	0.0062	CcSEcCtD
Dronedarone—Vasculitis—Dexamethasone—multiple sclerosis	0.000942	0.00618	CcSEcCtD
Dronedarone—Vasculitis—Betamethasone—multiple sclerosis	0.000942	0.00618	CcSEcCtD
Dronedarone—Pneumonia—Azathioprine—multiple sclerosis	0.000934	0.00613	CcSEcCtD
Dronedarone—Angiopathy—Cladribine—multiple sclerosis	0.000931	0.00611	CcSEcCtD
Dronedarone—Immune system disorder—Cladribine—multiple sclerosis	0.000926	0.00608	CcSEcCtD
Dronedarone—Mediastinal disorder—Cladribine—multiple sclerosis	0.000924	0.00607	CcSEcCtD
Dronedarone—Asthenia—Fingolimod—multiple sclerosis	0.000922	0.00606	CcSEcCtD
Dronedarone—Blood creatinine increased—Mitoxantrone—multiple sclerosis	0.000913	0.00599	CcSEcCtD
Dronedarone—Pruritus—Fingolimod—multiple sclerosis	0.00091	0.00597	CcSEcCtD
Dronedarone—Erythema—Cladribine—multiple sclerosis	0.000893	0.00586	CcSEcCtD
Dronedarone—Hypokalaemia—Mitoxantrone—multiple sclerosis	0.000887	0.00582	CcSEcCtD
Dronedarone—Cardiac failure congestive—Prednisolone—multiple sclerosis	0.000882	0.00579	CcSEcCtD
Dronedarone—Diarrhoea—Fingolimod—multiple sclerosis	0.00088	0.00577	CcSEcCtD
Dronedarone—Hepatobiliary disease—Azathioprine—multiple sclerosis	0.000879	0.00577	CcSEcCtD
Dronedarone—CACNB2—nervous system—multiple sclerosis	0.000854	0.00647	CbGeAlD
Dronedarone—SCN1A—nervous system—multiple sclerosis	0.00083	0.00628	CbGeAlD
Dronedarone—CACNB2—central nervous system—multiple sclerosis	0.000822	0.00622	CbGeAlD
Dronedarone—Vasculitis—Prednisone—multiple sclerosis	0.00082	0.00538	CcSEcCtD
Dronedarone—ADRA1A—brainstem—multiple sclerosis	0.000812	0.00614	CbGeAlD
Dronedarone—Cardiac failure congestive—Triamcinolone—multiple sclerosis	0.000811	0.00532	CcSEcCtD
Dronedarone—Cardiac failure congestive—Methylprednisolone—multiple sclerosis	0.000809	0.00531	CcSEcCtD
Dronedarone—CACNB2—cerebellum—multiple sclerosis	0.000804	0.00608	CbGeAlD
Dronedarone—SCN1A—central nervous system—multiple sclerosis	0.000799	0.00605	CbGeAlD
Dronedarone—SCN1A—cerebellum—multiple sclerosis	0.000781	0.00591	CbGeAlD
Dronedarone—ADRA1B—nervous system—multiple sclerosis	0.000757	0.00573	CbGeAlD
Dronedarone—Pneumonia—Mitoxantrone—multiple sclerosis	0.000755	0.00496	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.000755	0.00496	CcSEcCtD
Dronedarone—Immune system disorder—Azathioprine—multiple sclerosis	0.000753	0.00495	CcSEcCtD
Dronedarone—Cardiac failure—Methylprednisolone—multiple sclerosis	0.000752	0.00494	CcSEcCtD
Dronedarone—Mediastinal disorder—Azathioprine—multiple sclerosis	0.000752	0.00493	CcSEcCtD
Dronedarone—CACNA1D—nervous system—multiple sclerosis	0.000747	0.00565	CbGeAlD
Dronedarone—ADRA1D—nervous system—multiple sclerosis	0.00074	0.0056	CbGeAlD
Dronedarone—Cardiac failure congestive—Betamethasone—multiple sclerosis	0.000736	0.00483	CcSEcCtD
Dronedarone—Cardiac failure congestive—Dexamethasone—multiple sclerosis	0.000736	0.00483	CcSEcCtD
Dronedarone—ADRA1B—central nervous system—multiple sclerosis	0.000729	0.00552	CbGeAlD
Dronedarone—CACNA1D—central nervous system—multiple sclerosis	0.000719	0.00544	CbGeAlD
Dronedarone—Nervous system disorder—Cladribine—multiple sclerosis	0.000715	0.00469	CcSEcCtD
Dronedarone—ADRA1D—central nervous system—multiple sclerosis	0.000713	0.00539	CbGeAlD
Dronedarone—Skin disorder—Cladribine—multiple sclerosis	0.000708	0.00465	CcSEcCtD
Dronedarone—CACNA1D—cerebellum—multiple sclerosis	0.000703	0.00532	CbGeAlD
Dronedarone—CACNA1C—nervous system—multiple sclerosis	0.000689	0.00522	CbGeAlD
Dronedarone—Bradycardia—Mitoxantrone—multiple sclerosis	0.000686	0.00451	CcSEcCtD
Dronedarone—Vasculitis—Methotrexate—multiple sclerosis	0.000685	0.0045	CcSEcCtD
Dronedarone—Cardiac failure—Dexamethasone—multiple sclerosis	0.000684	0.00449	CcSEcCtD
Dronedarone—Cardiac failure—Betamethasone—multiple sclerosis	0.000684	0.00449	CcSEcCtD
Dronedarone—CACNA1C—central nervous system—multiple sclerosis	0.000664	0.00502	CbGeAlD
Dronedarone—CACNB2—brain—multiple sclerosis	0.000653	0.00494	CbGeAlD
Dronedarone—CACNA1C—cerebellum—multiple sclerosis	0.000649	0.00491	CbGeAlD
Dronedarone—Cardiac failure congestive—Prednisone—multiple sclerosis	0.000641	0.00421	CcSEcCtD
Dronedarone—SCN1A—brain—multiple sclerosis	0.000635	0.0048	CbGeAlD
Dronedarone—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000629	0.00413	CcSEcCtD
Dronedarone—Fatigue—Cladribine—multiple sclerosis	0.000628	0.00412	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000614	0.00403	CcSEcCtD
Dronedarone—Hypokalaemia—Dexamethasone—multiple sclerosis	0.000607	0.00399	CcSEcCtD
Dronedarone—Hypokalaemia—Betamethasone—multiple sclerosis	0.000607	0.00399	CcSEcCtD
Dronedarone—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000596	0.00391	CcSEcCtD
Dronedarone—Cardiac failure—Prednisone—multiple sclerosis	0.000595	0.00391	CcSEcCtD
Dronedarone—Erythema—Mitoxantrone—multiple sclerosis	0.000587	0.00385	CcSEcCtD
Dronedarone—ADRA1B—brain—multiple sclerosis	0.000578	0.00438	CbGeAlD
Dronedarone—Abdominal pain—Cladribine—multiple sclerosis	0.000576	0.00378	CcSEcCtD
Dronedarone—Skin disorder—Azathioprine—multiple sclerosis	0.000576	0.00378	CcSEcCtD
Dronedarone—Dysgeusia—Mitoxantrone—multiple sclerosis	0.000575	0.00377	CcSEcCtD
Dronedarone—CACNA1D—brain—multiple sclerosis	0.000571	0.00432	CbGeAlD
Dronedarone—ADRA1D—brain—multiple sclerosis	0.000566	0.00428	CbGeAlD
Dronedarone—Bradycardia—Prednisolone—multiple sclerosis	0.000563	0.0037	CcSEcCtD
Dronedarone—KCNH2—medulla oblongata—multiple sclerosis	0.000547	0.00414	CbGeAlD
Dronedarone—ADRA2C—medulla oblongata—multiple sclerosis	0.000539	0.00408	CbGeAlD
Dronedarone—ADRB1—nervous system—multiple sclerosis	0.000538	0.00407	CbGeAlD
Dronedarone—Hypokalaemia—Prednisone—multiple sclerosis	0.000529	0.00347	CcSEcCtD
Dronedarone—CACNA1C—brain—multiple sclerosis	0.000527	0.00399	CbGeAlD
Dronedarone—Asthenia—Cladribine—multiple sclerosis	0.000523	0.00343	CcSEcCtD
Dronedarone—Bradycardia—Triamcinolone—multiple sclerosis	0.000518	0.0034	CcSEcCtD
Dronedarone—ADRB1—central nervous system—multiple sclerosis	0.000518	0.00392	CbGeAlD
Dronedarone—Bradycardia—Methylprednisolone—multiple sclerosis	0.000517	0.00339	CcSEcCtD
Dronedarone—Pruritus—Cladribine—multiple sclerosis	0.000516	0.00338	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000512	0.00336	CcSEcCtD
Dronedarone—KCNH2—midbrain—multiple sclerosis	0.0005	0.00378	CbGeAlD
Dronedarone—Diarrhoea—Cladribine—multiple sclerosis	0.000499	0.00327	CcSEcCtD
Dronedarone—ADRA2C—midbrain—multiple sclerosis	0.000493	0.00373	CbGeAlD
Dronedarone—KCNH2—spinal cord—multiple sclerosis	0.000487	0.00369	CbGeAlD
Dronedarone—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000485	0.00318	CcSEcCtD
Dronedarone—Erythema—Prednisolone—multiple sclerosis	0.000481	0.00316	CcSEcCtD
Dronedarone—ADRA2C—spinal cord—multiple sclerosis	0.000481	0.00364	CbGeAlD
Dronedarone—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000479	0.00314	CcSEcCtD
Dronedarone—CYP2D6—brainstem—multiple sclerosis	0.000478	0.00362	CbGeAlD
Dronedarone—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000471	0.00309	CcSEcCtD
Dronedarone—Bradycardia—Betamethasone—multiple sclerosis	0.00047	0.00308	CcSEcCtD
Dronedarone—Bradycardia—Dexamethasone—multiple sclerosis	0.00047	0.00308	CcSEcCtD
Dronedarone—Abdominal pain—Azathioprine—multiple sclerosis	0.000468	0.00308	CcSEcCtD
Dronedarone—Skin disorder—Mitoxantrone—multiple sclerosis	0.000465	0.00305	CcSEcCtD
Dronedarone—Vomiting—Cladribine—multiple sclerosis	0.000463	0.00304	CcSEcCtD
Dronedarone—Angiopathy—Methylprednisolone—multiple sclerosis	0.00046	0.00302	CcSEcCtD
Dronedarone—Rash—Cladribine—multiple sclerosis	0.000459	0.00302	CcSEcCtD
Dronedarone—Dermatitis—Cladribine—multiple sclerosis	0.000459	0.00301	CcSEcCtD
Dronedarone—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000458	0.00301	CcSEcCtD
Dronedarone—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000457	0.003	CcSEcCtD
Dronedarone—Erythema—Triamcinolone—multiple sclerosis	0.000443	0.00291	CcSEcCtD
Dronedarone—Erythema—Methylprednisolone—multiple sclerosis	0.000442	0.0029	CcSEcCtD
Dronedarone—Angioedema—Prednisolone—multiple sclerosis	0.00044	0.00289	CcSEcCtD
Dronedarone—Dysgeusia—Triamcinolone—multiple sclerosis	0.000434	0.00285	CcSEcCtD
Dronedarone—Nausea—Cladribine—multiple sclerosis	0.000433	0.00284	CcSEcCtD
Dronedarone—ADRA2A—medulla oblongata—multiple sclerosis	0.00043	0.00326	CbGeAlD
Dronedarone—ADRA1A—nervous system—multiple sclerosis	0.000425	0.00322	CbGeAlD
Dronedarone—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000422	0.00277	CcSEcCtD
Dronedarone—Angiopathy—Betamethasone—multiple sclerosis	0.000419	0.00275	CcSEcCtD
Dronedarone—Angiopathy—Dexamethasone—multiple sclerosis	0.000419	0.00275	CcSEcCtD
Dronedarone—Fatigue—Mitoxantrone—multiple sclerosis	0.000413	0.00271	CcSEcCtD
Dronedarone—ADRB1—brain—multiple sclerosis	0.000411	0.00311	CbGeAlD
Dronedarone—KCNH2—nervous system—multiple sclerosis	0.000411	0.00311	CbGeAlD
Dronedarone—ADRA1A—central nervous system—multiple sclerosis	0.000409	0.0031	CbGeAlD
Dronedarone—Bradycardia—Prednisone—multiple sclerosis	0.000409	0.00269	CcSEcCtD
Dronedarone—ALB—brain—multiple sclerosis	0.000409	0.00309	CbGeAlD
Dronedarone—Diarrhoea—Azathioprine—multiple sclerosis	0.000405	0.00266	CcSEcCtD
Dronedarone—ADRA2C—nervous system—multiple sclerosis	0.000405	0.00307	CbGeAlD
Dronedarone—Angioedema—Triamcinolone—multiple sclerosis	0.000405	0.00266	CcSEcCtD
Dronedarone—Angioedema—Methylprednisolone—multiple sclerosis	0.000404	0.00265	CcSEcCtD
Dronedarone—Erythema—Betamethasone—multiple sclerosis	0.000402	0.00264	CcSEcCtD
Dronedarone—Erythema—Dexamethasone—multiple sclerosis	0.000402	0.00264	CcSEcCtD
Dronedarone—ADRA1A—cerebellum—multiple sclerosis	0.0004	0.00303	CbGeAlD
Dronedarone—KCNH2—central nervous system—multiple sclerosis	0.000395	0.00299	CbGeAlD
Dronedarone—ADRA2A—midbrain—multiple sclerosis	0.000393	0.00298	CbGeAlD
Dronedarone—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000393	0.00258	CcSEcCtD
Dronedarone—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000392	0.00257	CcSEcCtD
Dronedarone—ADRA2C—central nervous system—multiple sclerosis	0.00039	0.00295	CbGeAlD
Dronedarone—KCNH2—cerebellum—multiple sclerosis	0.000386	0.00292	CbGeAlD
Dronedarone—ADRA2A—spinal cord—multiple sclerosis	0.000384	0.0029	CbGeAlD
Dronedarone—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000383	0.00251	CcSEcCtD
Dronedarone—ADRA2C—cerebellum—multiple sclerosis	0.000381	0.00289	CbGeAlD
Dronedarone—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000379	0.00249	CcSEcCtD
Dronedarone—Vomiting—Azathioprine—multiple sclerosis	0.000377	0.00247	CcSEcCtD
Dronedarone—Pneumonia—Methotrexate—multiple sclerosis	0.000376	0.00247	CcSEcCtD
Dronedarone—Rash—Azathioprine—multiple sclerosis	0.000374	0.00245	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000374	0.00245	CcSEcCtD
Dronedarone—Dermatitis—Azathioprine—multiple sclerosis	0.000373	0.00245	CcSEcCtD
Dronedarone—Angioedema—Dexamethasone—multiple sclerosis	0.000367	0.00241	CcSEcCtD
Dronedarone—Angioedema—Betamethasone—multiple sclerosis	0.000367	0.00241	CcSEcCtD
Dronedarone—Angiopathy—Prednisone—multiple sclerosis	0.000365	0.00239	CcSEcCtD
Dronedarone—Immune system disorder—Prednisone—multiple sclerosis	0.000363	0.00238	CcSEcCtD
Dronedarone—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000361	0.00237	CcSEcCtD
Dronedarone—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000361	0.00237	CcSEcCtD
Dronedarone—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000354	0.00232	CcSEcCtD
Dronedarone—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000354	0.00232	CcSEcCtD
Dronedarone—Nausea—Azathioprine—multiple sclerosis	0.000352	0.00231	CcSEcCtD
Dronedarone—Skin disorder—Methylprednisolone—multiple sclerosis	0.00035	0.0023	CcSEcCtD
Dronedarone—Erythema—Prednisone—multiple sclerosis	0.00035	0.0023	CcSEcCtD
Dronedarone—Asthenia—Mitoxantrone—multiple sclerosis	0.000344	0.00226	CcSEcCtD
Dronedarone—ABCB1—retina—multiple sclerosis	0.000332	0.00251	CbGeAlD
Dronedarone—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000328	0.00215	CcSEcCtD
Dronedarone—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000328	0.00215	CcSEcCtD
Dronedarone—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000328	0.00215	CcSEcCtD
Dronedarone—ADRA1A—brain—multiple sclerosis	0.000325	0.00246	CbGeAlD
Dronedarone—ADRA2A—nervous system—multiple sclerosis	0.000323	0.00245	CbGeAlD
Dronedarone—Nervous system disorder—Betamethasone—multiple sclerosis	0.000322	0.00211	CcSEcCtD
Dronedarone—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000322	0.00211	CcSEcCtD
Dronedarone—Angioedema—Prednisone—multiple sclerosis	0.00032	0.0021	CcSEcCtD
Dronedarone—Dyspepsia—Triamcinolone—multiple sclerosis	0.000318	0.00209	CcSEcCtD
Dronedarone—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000317	0.00208	CcSEcCtD
Dronedarone—KCNH2—brain—multiple sclerosis	0.000314	0.00238	CbGeAlD
Dronedarone—Cardiac disorder—Methotrexate—multiple sclerosis	0.000312	0.00205	CcSEcCtD
Dronedarone—Fatigue—Triamcinolone—multiple sclerosis	0.000312	0.00205	CcSEcCtD
Dronedarone—ADRA2A—central nervous system—multiple sclerosis	0.000311	0.00236	CbGeAlD
Dronedarone—Fatigue—Methylprednisolone—multiple sclerosis	0.000311	0.00204	CcSEcCtD
Dronedarone—ADRA2C—brain—multiple sclerosis	0.00031	0.00234	CbGeAlD
Dronedarone—Angiopathy—Methotrexate—multiple sclerosis	0.000305	0.002	CcSEcCtD
Dronedarone—Vomiting—Mitoxantrone—multiple sclerosis	0.000305	0.002	CcSEcCtD
Dronedarone—ADRA2A—cerebellum—multiple sclerosis	0.000304	0.0023	CbGeAlD
Dronedarone—Immune system disorder—Methotrexate—multiple sclerosis	0.000303	0.00199	CcSEcCtD
Dronedarone—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000303	0.00199	CcSEcCtD
Dronedarone—Rash—Mitoxantrone—multiple sclerosis	0.000302	0.00198	CcSEcCtD
Dronedarone—Dermatitis—Mitoxantrone—multiple sclerosis	0.000302	0.00198	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000296	0.00194	CcSEcCtD
Dronedarone—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000295	0.00194	CcSEcCtD
Dronedarone—Erythema—Methotrexate—multiple sclerosis	0.000292	0.00192	CcSEcCtD
Dronedarone—Dyspepsia—Dexamethasone—multiple sclerosis	0.000289	0.00189	CcSEcCtD
Dronedarone—Dyspepsia—Betamethasone—multiple sclerosis	0.000289	0.00189	CcSEcCtD
Dronedarone—Dysgeusia—Methotrexate—multiple sclerosis	0.000286	0.00188	CcSEcCtD
Dronedarone—Anaphylactic shock—Prednisone—multiple sclerosis	0.000286	0.00187	CcSEcCtD
Dronedarone—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000285	0.00187	CcSEcCtD
Dronedarone—Nausea—Mitoxantrone—multiple sclerosis	0.000285	0.00187	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000283	0.00186	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000283	0.00186	CcSEcCtD
Dronedarone—Fatigue—Betamethasone—multiple sclerosis	0.000283	0.00186	CcSEcCtD
Dronedarone—Fatigue—Dexamethasone—multiple sclerosis	0.000283	0.00186	CcSEcCtD
Dronedarone—Nervous system disorder—Prednisone—multiple sclerosis	0.00028	0.00184	CcSEcCtD
Dronedarone—Skin disorder—Prednisone—multiple sclerosis	0.000277	0.00182	CcSEcCtD
Dronedarone—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000268	0.00176	CcSEcCtD
Dronedarone—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000268	0.00176	CcSEcCtD
Dronedarone—Asthenia—Triamcinolone—multiple sclerosis	0.000259	0.0017	CcSEcCtD
Dronedarone—Abdominal pain—Betamethasone—multiple sclerosis	0.000259	0.0017	CcSEcCtD
Dronedarone—Abdominal pain—Dexamethasone—multiple sclerosis	0.000259	0.0017	CcSEcCtD
Dronedarone—Asthenia—Methylprednisolone—multiple sclerosis	0.000259	0.0017	CcSEcCtD
Dronedarone—Pruritus—Triamcinolone—multiple sclerosis	0.000256	0.00168	CcSEcCtD
Dronedarone—Pruritus—Methylprednisolone—multiple sclerosis	0.000255	0.00167	CcSEcCtD
Dronedarone—CYP3A4—nervous system—multiple sclerosis	0.000254	0.00193	CbGeAlD
Dronedarone—Dyspepsia—Prednisone—multiple sclerosis	0.000251	0.00165	CcSEcCtD
Dronedarone—CYP2D6—nervous system—multiple sclerosis	0.00025	0.0019	CbGeAlD
Dronedarone—Rash—Prednisolone—multiple sclerosis	0.000248	0.00163	CcSEcCtD
Dronedarone—Dermatitis—Prednisolone—multiple sclerosis	0.000248	0.00163	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000247	0.00162	CcSEcCtD
Dronedarone—ADRA2A—brain—multiple sclerosis	0.000247	0.00187	CbGeAlD
Dronedarone—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000247	0.00162	CcSEcCtD
Dronedarone—Fatigue—Prednisone—multiple sclerosis	0.000246	0.00162	CcSEcCtD
Dronedarone—CYP3A4—central nervous system—multiple sclerosis	0.000245	0.00185	CbGeAlD
Dronedarone—CYP2D6—central nervous system—multiple sclerosis	0.000241	0.00182	CbGeAlD
Dronedarone—ABCB1—medulla oblongata—multiple sclerosis	0.00024	0.00181	CbGeAlD
Dronedarone—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000239	0.00157	CcSEcCtD
Dronedarone—CYP2D6—cerebellum—multiple sclerosis	0.000236	0.00178	CbGeAlD
Dronedarone—Asthenia—Dexamethasone—multiple sclerosis	0.000235	0.00154	CcSEcCtD
Dronedarone—Asthenia—Betamethasone—multiple sclerosis	0.000235	0.00154	CcSEcCtD
Dronedarone—Nervous system disorder—Methotrexate—multiple sclerosis	0.000234	0.00154	CcSEcCtD
Dronedarone—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000234	0.00153	CcSEcCtD
Dronedarone—Nausea—Prednisolone—multiple sclerosis	0.000233	0.00153	CcSEcCtD
Dronedarone—Pruritus—Dexamethasone—multiple sclerosis	0.000232	0.00152	CcSEcCtD
Dronedarone—Pruritus—Betamethasone—multiple sclerosis	0.000232	0.00152	CcSEcCtD
Dronedarone—Skin disorder—Methotrexate—multiple sclerosis	0.000232	0.00152	CcSEcCtD
Dronedarone—Vomiting—Triamcinolone—multiple sclerosis	0.00023	0.00151	CcSEcCtD
Dronedarone—Vomiting—Methylprednisolone—multiple sclerosis	0.000229	0.00151	CcSEcCtD
Dronedarone—Rash—Triamcinolone—multiple sclerosis	0.000228	0.0015	CcSEcCtD
Dronedarone—Dermatitis—Triamcinolone—multiple sclerosis	0.000228	0.00149	CcSEcCtD
Dronedarone—Rash—Methylprednisolone—multiple sclerosis	0.000227	0.00149	CcSEcCtD
Dronedarone—Dermatitis—Methylprednisolone—multiple sclerosis	0.000227	0.00149	CcSEcCtD
Dronedarone—Abdominal pain—Prednisone—multiple sclerosis	0.000226	0.00148	CcSEcCtD
Dronedarone—Diarrhoea—Betamethasone—multiple sclerosis	0.000224	0.00147	CcSEcCtD
Dronedarone—Diarrhoea—Dexamethasone—multiple sclerosis	0.000224	0.00147	CcSEcCtD
Dronedarone—ABCB1—midbrain—multiple sclerosis	0.000219	0.00166	CbGeAlD
Dronedarone—Nausea—Triamcinolone—multiple sclerosis	0.000215	0.00141	CcSEcCtD
Dronedarone—Nausea—Methylprednisolone—multiple sclerosis	0.000214	0.00141	CcSEcCtD
Dronedarone—ABCB1—spinal cord—multiple sclerosis	0.000214	0.00162	CbGeAlD
Dronedarone—Dyspepsia—Methotrexate—multiple sclerosis	0.00021	0.00138	CcSEcCtD
Dronedarone—Vomiting—Dexamethasone—multiple sclerosis	0.000208	0.00137	CcSEcCtD
Dronedarone—Vomiting—Betamethasone—multiple sclerosis	0.000208	0.00137	CcSEcCtD
Dronedarone—Rash—Betamethasone—multiple sclerosis	0.000207	0.00136	CcSEcCtD
Dronedarone—Rash—Dexamethasone—multiple sclerosis	0.000207	0.00136	CcSEcCtD
Dronedarone—Dermatitis—Betamethasone—multiple sclerosis	0.000207	0.00136	CcSEcCtD
Dronedarone—Dermatitis—Dexamethasone—multiple sclerosis	0.000207	0.00136	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000206	0.00135	CcSEcCtD
Dronedarone—Fatigue—Methotrexate—multiple sclerosis	0.000206	0.00135	CcSEcCtD
Dronedarone—Asthenia—Prednisone—multiple sclerosis	0.000205	0.00135	CcSEcCtD
Dronedarone—Pruritus—Prednisone—multiple sclerosis	0.000202	0.00133	CcSEcCtD
Dronedarone—Diarrhoea—Prednisone—multiple sclerosis	0.000195	0.00128	CcSEcCtD
Dronedarone—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000195	0.00128	CcSEcCtD
Dronedarone—Nausea—Dexamethasone—multiple sclerosis	0.000195	0.00128	CcSEcCtD
Dronedarone—Nausea—Betamethasone—multiple sclerosis	0.000195	0.00128	CcSEcCtD
Dronedarone—CYP2D6—brain—multiple sclerosis	0.000191	0.00145	CbGeAlD
Dronedarone—Abdominal pain—Methotrexate—multiple sclerosis	0.000189	0.00124	CcSEcCtD
Dronedarone—Vomiting—Prednisone—multiple sclerosis	0.000182	0.00119	CcSEcCtD
Dronedarone—ABCB1—nervous system—multiple sclerosis	0.00018	0.00136	CbGeAlD
Dronedarone—Rash—Prednisone—multiple sclerosis	0.00018	0.00118	CcSEcCtD
Dronedarone—Dermatitis—Prednisone—multiple sclerosis	0.00018	0.00118	CcSEcCtD
Dronedarone—ABCB1—central nervous system—multiple sclerosis	0.000173	0.00131	CbGeAlD
Dronedarone—Asthenia—Methotrexate—multiple sclerosis	0.000171	0.00112	CcSEcCtD
Dronedarone—Nausea—Prednisone—multiple sclerosis	0.00017	0.00111	CcSEcCtD
Dronedarone—ABCB1—cerebellum—multiple sclerosis	0.00017	0.00128	CbGeAlD
Dronedarone—Pruritus—Methotrexate—multiple sclerosis	0.000169	0.00111	CcSEcCtD
Dronedarone—Diarrhoea—Methotrexate—multiple sclerosis	0.000163	0.00107	CcSEcCtD
Dronedarone—Vomiting—Methotrexate—multiple sclerosis	0.000152	0.000996	CcSEcCtD
Dronedarone—Rash—Methotrexate—multiple sclerosis	0.00015	0.000988	CcSEcCtD
Dronedarone—Dermatitis—Methotrexate—multiple sclerosis	0.00015	0.000987	CcSEcCtD
Dronedarone—Nausea—Methotrexate—multiple sclerosis	0.000142	0.000931	CcSEcCtD
Dronedarone—ABCB1—brain—multiple sclerosis	0.000138	0.00104	CbGeAlD
Dronedarone—ADRA1B—Signaling Pathways—CXCR3—multiple sclerosis	1.56e-05	9.9e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—POMC—multiple sclerosis	1.55e-05	9.9e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.55e-05	9.88e-05	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—POMC—multiple sclerosis	1.55e-05	9.84e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CD28—multiple sclerosis	1.54e-05	9.81e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CCR2—multiple sclerosis	1.54e-05	9.79e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CNR1—multiple sclerosis	1.53e-05	9.76e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—CCL2—multiple sclerosis	1.52e-05	9.68e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CNR1—multiple sclerosis	1.52e-05	9.67e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CXCL10—multiple sclerosis	1.51e-05	9.65e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CCR2—multiple sclerosis	1.51e-05	9.63e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—CCL5—multiple sclerosis	1.51e-05	9.63e-05	CbGpPWpGaD
Dronedarone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.51e-05	9.59e-05	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—CCR5—multiple sclerosis	1.5e-05	9.55e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	1.49e-05	9.46e-05	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	1.48e-05	9.41e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	1.47e-05	9.34e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—BCHE—multiple sclerosis	1.46e-05	9.27e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	1.44e-05	9.2e-05	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—POMC—multiple sclerosis	1.44e-05	9.19e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	1.43e-05	9.11e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.42e-05	9.07e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.42e-05	9.07e-05	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—POMC—multiple sclerosis	1.42e-05	9.05e-05	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—ALB—multiple sclerosis	1.42e-05	9.04e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CNR1—multiple sclerosis	1.42e-05	9.03e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—POMC—multiple sclerosis	1.42e-05	9.02e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Hemostasis—TGFB1—multiple sclerosis	1.41e-05	8.98e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	1.41e-05	8.97e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—POMC—multiple sclerosis	1.4e-05	8.93e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CNR1—multiple sclerosis	1.4e-05	8.89e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—CCL2—multiple sclerosis	1.39e-05	8.82e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Hemostasis—MAPK1—multiple sclerosis	1.38e-05	8.8e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	1.38e-05	8.8e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—TYK2—multiple sclerosis	1.38e-05	8.79e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CCL3—multiple sclerosis	1.38e-05	8.79e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CXCL10—multiple sclerosis	1.38e-05	8.79e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—CCL2—multiple sclerosis	1.37e-05	8.74e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—IL2—multiple sclerosis	1.37e-05	8.73e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	1.37e-05	8.71e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CXCL10—multiple sclerosis	1.37e-05	8.71e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—CCR5—multiple sclerosis	1.36e-05	8.67e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	1.34e-05	8.56e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—IL2RA—multiple sclerosis	1.34e-05	8.55e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.33e-05	8.49e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PTGER4—multiple sclerosis	1.33e-05	8.46e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CD86—multiple sclerosis	1.32e-05	8.43e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Hemostasis—TGFB1—multiple sclerosis	1.32e-05	8.39e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—POMC—multiple sclerosis	1.31e-05	8.35e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PGR—multiple sclerosis	1.31e-05	8.34e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CCL5—multiple sclerosis	1.3e-05	8.3e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.3e-05	8.3e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Hemostasis—MAPK1—multiple sclerosis	1.29e-05	8.22e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—POMC—multiple sclerosis	1.29e-05	8.21e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CXCR3—multiple sclerosis	1.28e-05	8.17e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—CCL2—multiple sclerosis	1.28e-05	8.17e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CXCL10—multiple sclerosis	1.28e-05	8.13e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CD28—multiple sclerosis	1.27e-05	8.1e-05	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR downstream signaling—IL2—multiple sclerosis	1.27e-05	8.06e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—CCL2—multiple sclerosis	1.26e-05	8.04e-05	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	1.26e-05	8.03e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—TYK2—multiple sclerosis	1.26e-05	8.01e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CXCL10—multiple sclerosis	1.26e-05	8.01e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CCR2—multiple sclerosis	1.25e-05	7.95e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—TYK2—multiple sclerosis	1.25e-05	7.94e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	1.24e-05	7.9e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—SPP1—multiple sclerosis	1.21e-05	7.69e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CD86—multiple sclerosis	1.21e-05	7.68e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CD86—multiple sclerosis	1.2e-05	7.61e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CCL5—multiple sclerosis	1.19e-05	7.57e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CCL5—multiple sclerosis	1.18e-05	7.5e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CCR5—multiple sclerosis	1.17e-05	7.48e-05	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—POMC—multiple sclerosis	1.17e-05	7.47e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—TYK2—multiple sclerosis	1.16e-05	7.42e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IL2RA—multiple sclerosis	1.16e-05	7.37e-05	CbGpPWpGaD
Dronedarone—ADRB1—GPCR downstream signaling—IL2—multiple sclerosis	1.15e-05	7.34e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	1.15e-05	7.34e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—IL2—multiple sclerosis	1.15e-05	7.32e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—BCHE—multiple sclerosis	1.15e-05	7.31e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—TYK2—multiple sclerosis	1.15e-05	7.3e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	1.15e-05	7.3e-05	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—IL2—multiple sclerosis	1.14e-05	7.27e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	1.12e-05	7.14e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CD86—multiple sclerosis	1.12e-05	7.11e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	1.12e-05	7.11e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—SPP1—multiple sclerosis	1.1e-05	7.01e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CCL5—multiple sclerosis	1.1e-05	7e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CD86—multiple sclerosis	1.1e-05	7e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—SPP1—multiple sclerosis	1.09e-05	6.94e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—IL2—multiple sclerosis	1.08e-05	6.89e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CCL5—multiple sclerosis	1.08e-05	6.89e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.08e-05	6.87e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—APOE—multiple sclerosis	1.08e-05	6.86e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CCR5—multiple sclerosis	1.07e-05	6.82e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	1.07e-05	6.81e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—APOE—multiple sclerosis	1.07e-05	6.81e-05	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—IL2—multiple sclerosis	1.07e-05	6.79e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	1.06e-05	6.78e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CCR5—multiple sclerosis	1.06e-05	6.75e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IL2RA—multiple sclerosis	1.05e-05	6.72e-05	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—IL2—multiple sclerosis	1.05e-05	6.69e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	1.05e-05	6.68e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—IL2—multiple sclerosis	1.05e-05	6.67e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IL2RA—multiple sclerosis	1.05e-05	6.66e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	1.04e-05	6.63e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	1.04e-05	6.61e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—IL2—multiple sclerosis	1.04e-05	6.61e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—SPP1—multiple sclerosis	1.02e-05	6.48e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	1.02e-05	6.48e-05	CbGpPWpGaD
Dronedarone—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.01e-05	6.45e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—BCHE—multiple sclerosis	1.01e-05	6.41e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—SPP1—multiple sclerosis	1e-05	6.38e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CCR5—multiple sclerosis	9.91e-06	6.31e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	9.76e-06	6.22e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL2RA—multiple sclerosis	9.76e-06	6.22e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CCR5—multiple sclerosis	9.75e-06	6.21e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—APOE—multiple sclerosis	9.74e-06	6.2e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—IL2—multiple sclerosis	9.69e-06	6.17e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CD80—multiple sclerosis	9.66e-06	6.15e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—APOE—multiple sclerosis	9.65e-06	6.14e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	9.61e-06	6.12e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL2RA—multiple sclerosis	9.61e-06	6.12e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—IL2—multiple sclerosis	9.54e-06	6.07e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—BCHE—multiple sclerosis	9.48e-06	6.04e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	9.46e-06	6.02e-05	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	9.33e-06	5.94e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—POMC—multiple sclerosis	9.26e-06	5.9e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—POMC—multiple sclerosis	9.18e-06	5.85e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	9.07e-06	5.78e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—APOE—multiple sclerosis	9.01e-06	5.74e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CCL2—multiple sclerosis	8.98e-06	5.72e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	8.93e-06	5.69e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	8.9e-06	5.67e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	8.87e-06	5.65e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CD80—multiple sclerosis	8.8e-06	5.61e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—MAPK1—multiple sclerosis	8.79e-06	5.6e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—APOE—multiple sclerosis	8.75e-06	5.57e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	8.72e-06	5.56e-05	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	8.67e-06	5.52e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	8.66e-06	5.51e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	8.53e-06	5.44e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	8.47e-06	5.39e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—TGFB1—multiple sclerosis	8.44e-06	5.38e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—ALB—multiple sclerosis	8.44e-06	5.38e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—POMC—multiple sclerosis	8.36e-06	5.33e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	8.29e-06	5.28e-05	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—MAPK1—multiple sclerosis	8.28e-06	5.27e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	8.27e-06	5.27e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CCL2—multiple sclerosis	8.18e-06	5.21e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—TYK2—multiple sclerosis	8.16e-06	5.19e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	8.15e-06	5.19e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	8.11e-06	5.16e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	8.05e-06	5.12e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	8.02e-06	5.11e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—MAPK1—multiple sclerosis	8.01e-06	5.1e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	7.93e-06	5.05e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	7.93e-06	5.05e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	7.88e-06	5.02e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	7.87e-06	5.01e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	7.74e-06	4.93e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	7.62e-06	4.85e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	7.58e-06	4.82e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—POMC—multiple sclerosis	7.52e-06	4.79e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	7.46e-06	4.75e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—TYK2—multiple sclerosis	7.43e-06	4.73e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	7.41e-06	4.72e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	7.36e-06	4.69e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	7.32e-06	4.66e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	7.29e-06	4.65e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	7.12e-06	4.54e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—APOE—multiple sclerosis	6.91e-06	4.4e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	6.88e-06	4.38e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—ALB—multiple sclerosis	6.86e-06	4.37e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IL2—multiple sclerosis	6.79e-06	4.32e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	6.77e-06	4.31e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	6.77e-06	4.31e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—IL6—multiple sclerosis	6.75e-06	4.3e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	6.62e-06	4.22e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	6.62e-06	4.21e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	6.48e-06	4.13e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MMP9—multiple sclerosis	6.42e-06	4.09e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	6.29e-06	4e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—BCHE—multiple sclerosis	6.2e-06	3.95e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IL2—multiple sclerosis	6.18e-06	3.94e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—IL6—multiple sclerosis	6.15e-06	3.92e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	6.15e-06	3.92e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	6.13e-06	3.9e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	6.1e-06	3.88e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—APOE—multiple sclerosis	6.05e-06	3.86e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	6.02e-06	3.83e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	6.01e-06	3.83e-05	CbGpPWpGaD
Dronedarone—ALB—Metabolism—POMC—multiple sclerosis	5.94e-06	3.78e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MMP9—multiple sclerosis	5.85e-06	3.73e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	5.8e-06	3.69e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	5.72e-06	3.64e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—STAT3—multiple sclerosis	5.71e-06	3.64e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—APOE—multiple sclerosis	5.7e-06	3.63e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	5.7e-06	3.63e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	5.63e-06	3.59e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	5.61e-06	3.57e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	5.59e-06	3.56e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	5.42e-06	3.45e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	5.33e-06	3.4e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MYC—multiple sclerosis	5.31e-06	3.38e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—TGFB1—multiple sclerosis	5.29e-06	3.37e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—STAT3—multiple sclerosis	5.2e-06	3.31e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—POMC—multiple sclerosis	5.2e-06	3.31e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—MAPK1—multiple sclerosis	5.19e-06	3.31e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	5.16e-06	3.28e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	5e-06	3.19e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	4.98e-06	3.17e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—POMC—multiple sclerosis	4.9e-06	3.12e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MYC—multiple sclerosis	4.84e-06	3.08e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—TGFB1—multiple sclerosis	4.82e-06	3.07e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	4.82e-06	3.07e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	4.79e-06	3.05e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	4.78e-06	3.04e-05	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—ALB—multiple sclerosis	4.74e-06	3.02e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	4.74e-06	3.02e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	4.74e-06	3.02e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MAPK1—multiple sclerosis	4.73e-06	3.01e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	4.69e-06	2.98e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	4.65e-06	2.96e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	4.63e-06	2.95e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	4.48e-06	2.85e-05	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—ALB—multiple sclerosis	4.47e-06	2.85e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	4.46e-06	2.84e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	4.4e-06	2.8e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	4.4e-06	2.8e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	4.39e-06	2.8e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	4.38e-06	2.79e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	4.31e-06	2.74e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	4.21e-06	2.68e-05	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IL6—multiple sclerosis	3.99e-06	2.54e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	3.91e-06	2.49e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	3.91e-06	2.49e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	3.9e-06	2.49e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	3.83e-06	2.44e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—APOE—multiple sclerosis	3.73e-06	2.38e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	3.64e-06	2.31e-05	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IL6—multiple sclerosis	3.63e-06	2.31e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	3.63e-06	2.31e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	3.6e-06	2.29e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	3.56e-06	2.26e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	3.36e-06	2.14e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	3.31e-06	2.11e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—POMC—multiple sclerosis	3.2e-06	2.04e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	2.94e-06	1.87e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ALB—multiple sclerosis	2.92e-06	1.86e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	2.73e-06	1.74e-05	CbGpPWpGaD
